BACKGROUND: Randomized controlled trials focusing on the effects of antidepressant treatment in cardiac patients have found modest effects on depressive symptoms but not on cardiac outcomes. A secondary analysis was conducted on data from the Enhancing Recovery in Coronary Heart Disease trial to assess whether changes in somatic or cognitive depressive symptoms following acute MI predicted event-free survival and whether the results differed per treatment arm (cognitive behavior therapy or care as usual). METHODS:Patients who met depression criteria and completed the 6th month depression assessment (n=1254) were included in this study. Measurements included demographic and clinical data and the Beck Depression Inventory at baseline and 6 months. The primary endpoint was a composite of recurrent MI and mortality over 2.4 years (standard deviation=0.9 years). RESULTS: Positive changes (per 1 point increase) in somatic depressive symptoms (HR: 0.95; 95% CI: 0.92-0.98; p=0.001) but not in cognitive depressive symptoms (HR: 0.98; 95% CI: 0.96-1.01; p=0.19) were related to a reduced risk of recurrent MI and mortality after adjustment for baseline depression scores. There was a trend for an interaction effect between changes in somatic depressive symptoms and the intervention (p=0.08). After controlling for demographic and clinical variables, the association between changes in somatic depressive symptoms and event-free survival remained significant in the intervention arm (HR: 0.93; 95% CI: 0.88-0.98; p=0.01) only. LIMITATIONS: Secondary analyses. CONCLUSIONS: Changes in somatic depressive symptoms, and not cognitive symptoms, were related to improved outcomes in the intervention arm, independent of demographic and clinical variables.
RCT Entities:
BACKGROUND: Randomized controlled trials focusing on the effects of antidepressant treatment in cardiac patients have found modest effects on depressive symptoms but not on cardiac outcomes. A secondary analysis was conducted on data from the Enhancing Recovery in Coronary Heart Disease trial to assess whether changes in somatic or cognitive depressive symptoms following acute MI predicted event-free survival and whether the results differed per treatment arm (cognitive behavior therapy or care as usual). METHODS:Patients who met depression criteria and completed the 6th month depression assessment (n=1254) were included in this study. Measurements included demographic and clinical data and the Beck Depression Inventory at baseline and 6 months. The primary endpoint was a composite of recurrent MI and mortality over 2.4 years (standard deviation=0.9 years). RESULTS: Positive changes (per 1 point increase) in somatic depressive symptoms (HR: 0.95; 95% CI: 0.92-0.98; p=0.001) but not in cognitive depressive symptoms (HR: 0.98; 95% CI: 0.96-1.01; p=0.19) were related to a reduced risk of recurrent MI and mortality after adjustment for baseline depression scores. There was a trend for an interaction effect between changes in somatic depressive symptoms and the intervention (p=0.08). After controlling for demographic and clinical variables, the association between changes in somatic depressive symptoms and event-free survival remained significant in the intervention arm (HR: 0.93; 95% CI: 0.88-0.98; p=0.01) only. LIMITATIONS: Secondary analyses. CONCLUSIONS: Changes in somatic depressive symptoms, and not cognitive symptoms, were related to improved outcomes in the intervention arm, independent of demographic and clinical variables.
Authors: Petra W Hoen; Mary A Whooley; Elisabeth J Martens; Beeya Na; Joost P van Melle; Peter de Jonge Journal: J Am Coll Cardiol Date: 2010-09-07 Impact factor: 24.094
Authors: Anna Meijer; Henk Jan Conradi; Elisabeth H Bos; Brett D Thombs; Joost P van Melle; Peter de Jonge Journal: Gen Hosp Psychiatry Date: 2011-03-31 Impact factor: 3.238
Authors: Annelieke M Roest; Robert M Carney; Phyllis K Stein; Kenneth E Freedland; Hilary Meyer; Brian C Steinmeyer; Peter de Jonge; Eugene H Rubin Journal: J Clin Psychiatry Date: 2011-08-09 Impact factor: 4.384
Authors: Ingrid Connerney; Richard P Sloan; Peter A Shapiro; Emilia Bagiella; Charlotte Seckman Journal: Psychosom Med Date: 2010-09-14 Impact factor: 4.312
Authors: Annelieke M Roest; Brett D Thombs; Sherry L Grace; Donna E Stewart; Susan E Abbey; Peter de Jonge Journal: J Affect Disord Date: 2010-12-14 Impact factor: 4.839
Authors: Angélique A Schiffer; Aline J Pelle; Otto R F Smith; Jos W Widdershoven; Eric H Hendriks; Susanne S Pedersen Journal: J Clin Psychiatry Date: 2009-07-28 Impact factor: 4.384
Authors: Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart Journal: Depress Anxiety Date: 2019-07-29 Impact factor: 6.505
Authors: Magdalena K Wekenborg; LaBarron K Hill; Julian F Thayer; Marlene Penz; Ralf Arne Wittling; Clemens Kirschbaum Journal: Psychosom Med Date: 2019 Nov/Dec Impact factor: 4.312
Authors: Misty A W Hawkins; Mary A Dolansky; Julie T Schaefer; Michael J Fulcher; John Gunstad; Joseph D Redle; Richard Josephson; Joel W Hughes Journal: J Cardiovasc Nurs Date: 2015 Sep-Oct Impact factor: 2.083
Authors: Sebastian Kohlmann; Benjamin Gierk; Alexandra M Murray; Arne Scholl; Marco Lehmann; Bernd Löwe Journal: PLoS One Date: 2016-05-26 Impact factor: 3.240